Special Issue "Approaches to Improve the Prognosis of Head-and-Neck Cancer"
Deadline for manuscript submissions: 31 December 2023 | Viewed by 4539
Interests: cancer cachexia; sarcopenia; nutrition; frailty
Head and neck cancer is considered a cancer with a very poor prognosis due to the anatomical characteristics of the head and neck region. Depending on the surgical site and its extent, head and neck cancer is prone to cause functional disabilities such as eating and swallowing disorders. As a result, the risk of developing nutritional disorders, frailty, and sarcopenia increases, ultimately leading to a poor prognosis. Recently, the number of elderly cancer patients aged 65 years or older has been growing every year. Although the number of survivors is increasing due to technological advances in surgical procedures and chemoradiotherapy, it is clear that serious sequelae and functional impairment cause a significant decline in patient QOL. Therefore, it is becoming increasingly important to properly evaluate patients’ conditions and make appropriate treatment choices at each stage of head and neck cancer treatment.
In this Special Issue, we would like to invite submissions on new findings regarding efforts to improve prognosis, especially in head and neck cancer. This Special Issue will provide a basis for new approaches that will lead to a better understanding of the pathogenesis of head and neck cancer and may lead to better treatment choices for patients and improve outcomes.
Dr. Hajime Suzuki
Prof. Dr. Norifumi Nakamura
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- head and neck cancer
- oral cancer
- postoperative complications
- survival rate